Zai Lab (NASDAQ:ZLAB) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.40) by 7.5 percent. This is a 54.88 percent increase over losses of $(0.82) per share from the same period last year. The company reported quarterly sales of $109.977 million which missed the analyst consensus estimate of $125.628 million by 12.46 percent. This is a 9.43 percent increase over sales of $100.504 million the same period last year.